Structure of Ginsenoside Rg1
CAS No.: 22427-39-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Ginsenoside Rg1, a natural product isolated and purified from the roots of Panax ginseng C. A. Mey., is a functional ligand of glucocorticoid receptor(GR) that can boost the production of insulin receptors, stimulates the creation of new blood vessels and wound healing, relaxes and widens blood vessels and lowers blood pressure, and is a potent phytoestrogen with estrogen-like activity.
Synonyms: Panaxoside Rg1; Panaxoside A; Sanchinoside Rg1
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 22427-39-0 |
Formula : | C42H72O14 |
M.W : | 801.01 |
SMILES Code : | C[C@@]12[C@@]([H])([C@](C)([C@]3([C@H](C2)O[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO)[H])CC[C@@H](C3(C)C)O)C[C@H]([C@]5([C@]1(CC[C@@H]5[C@@](C)(O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6O)O)O)CO)CC/C=C(C)\C)C)[H])O |
Synonyms : |
Panaxoside Rg1; Panaxoside A; Sanchinoside Rg1
|
MDL No. : | MFCD00210293 |
InChI Key : | YURJSTAIMNSZAE-HHNZYBFYSA-N |
Pubchem ID : | 441923 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Primary RGCs | 1, 10, 30 μM | 1 week | Promoted neurite growth of primary RGCs | PMC10920000 |
HeLa cells | 10 μM | 10 hours | Ginsenoside Rg1 reduced cancer cell proliferation through inducing mitotic arrest. | PMC9120780 |
RGC-5s cells | 1, 10, 30 μM | 2 days | Promoted neurite growth and synaptic plasticity of RGC-5s cells | PMC10920000 |
HepG2 cells | 0.1, 1 or 10 μM | 2 hours | To study the effect of Rg1 on the binding of Akt to FoxO1, results showed that Rg1 promoted Akt binding to FoxO1 and inhibited FoxO1 nuclear translocation. | PMC5667421 |
PC12 cells | 0.01 –1 μM | 24 hours | Rg1 significantly attenuated OGD/R-induced cell injury, accompanied by prolonging nuclear accumulation of Nrf2, enhancing the transcriptional activity of Nrf2, and promoting the expression of ARE-target genes. | PMC6318278 |
Hepatic stellate cells | 50 μM | 24 hours | Inhibited HSC proliferation and collagen expression, reducing liver fibrosis via EMT pathway inhibition | PMC10310870 |
HT22 cells | 5, 10 μM | 24 hours | To study the effect of Rg1 on calcium overload induced by OGD/R in HT22 cells, the results showed that Rg1 could inhibit calcium overload and resist the imbalance of calcium homeostasis. | PMC9270650 |
Pulmonary artery smooth muscle cells (PASMCs) | 20 μM | 24 hours | Ginsenoside Rg1 inhibits hypoxia-induced PASMCs proliferation, inflammation, and fibrosis by downregulating the calpain-1/STAT3 signaling pathway. | PMC11258379 |
Rat bone marrow-derived macrophages (BMDMs) | 1, 2, 4 μM | 24 hours | To investigate the effects of Rg1 on AIM2 inflammasome activation and macrophage polarization. Results showed that Rg1 significantly inhibited AIM2 inflammasome activation and reduced M1 macrophage polarization. | PMC11583468 |
Cardiac fibroblasts | 10 μM | 24 hours | Ginsenoside Rg1 reduced collagen I and III mRNA expression and inhibited cardiac fibroblast proliferation. | PMC8569322 |
Cardiomyocytes | 10 μM | 24 hours | Ginsenoside Rg1 inhibited stretch-induced cardiomyocyte hypertrophy and reduced ANP and BNP mRNA expression. | PMC8569322 |
Neuronal cells | 40 μM | 48 hours | To assess the effect of Rg1 pretreatment on EV secretion from neuronal cells, results showed that Rg1 pretreatment increased EV release. | PMC11336912 |
MC38 cells | 100 μM | Inhibit PD-1/PD-L1 binding | PMC10770033 | |
RPE1 cells | 10 μM | Ginsenoside Rg1 did not inhibit H3T3ph in normal cells. | PMC9120780 | |
DC2.4 cells | 2.5–100 μM | 24 hours | Promoted DC2.4 cell maturation and upregulated CD40 and CD86 expression | PMC11481235 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Sprague-Dawley rats | Traumatic brain injury model | Intraperitoneal injection | 5, 10, 15 mg/kg | 30 minutes and 24 hours after injury | Evaluated the protective effect of Rg1 on traumatic brain injury, results showed that Rg1 significantly improved neurological deficits, brain edema and BBB permeability | PMC8642604 |
C57BL/6J mice | High-fat diet-induced obese Mice model | Oral | 50 mg/kg | Once daily for 8 weeks | To investigate the effect of Rg1 on blood glucose and hepatic glucose production in high-fat diet-induced obese mice, results showed that Rg1 reduced fasting blood glucose, improved glucose tolerance, and suppressed the expression of hepatic gluconeogenesis-related enzymes. | PMC5667421 |
C57BL/6 mice | MC38 tumor xenograft lung metastasis model | Intraperitoneal injection | 100 mg/kg | Once daily for four weeks | Inhibit colon cancer lung metastasis and activate CD8 T cells | PMC10770033 |
Sprague-Dawley rats | Transient middle cerebral artery occlusion (tMCAO) model | Intraperitoneal injection | 20 mg/kg | Single dose, lasting for 24 hours | Rg1 significantly alleviated ischemic injury and activated the Nrf2/ARE pathway. The protective effects of Rg1 were abolished by injecting AAV-HIF-miR-144-shRNA into the predicted ischemic penumbra. | PMC6318278 |
C57BL/6 mice | 3-nitropropionic acid-induced Huntington's disease model | Oral | 10, 20, 40 mg/kg | Once daily for 5 days | Ginsenoside Rg1 exerts neuroprotective effects in the striatum by suppressing MAPKs and NF-κB pathways | PMC8379213 |
5XFAD mice | Alzheimer's disease model | Intraperitoneal injection | 10 mg/kg | Once daily for 30 consecutive days | Rg1 restores mitophagy and ameliorates memory deficits in the AD Mice model through the PINK1-Parkin pathway. | PMC10214288 |
C57BL/6J mice | CCl4-induced liver fibrosis model | Oral | 40 mg/kg | Twice a week for 8 weeks | Significantly reduced CCl4-induced liver fibrosis, decreased collagen deposition and a-SMA expression | PMC10310870 |
C57/BL mice | Type 2 diabetes model | Gavage | 1, 5 or 10 mg/kg | 8 weeks | Rg1 treatment improved memory impairment and neuronal injury, decreased ROS, IP3, and DAG levels to revert Ca2+ overload, downregulated the expressions of p-PLC, TRPC6, CN, and NFAT1 nuclear translocation, and alleviated Aβ deposition in T2DM mice. In addition, Rg1 treatment elevated the expression of PSD95 and SYN in T2DM mice, which in turn improved synaptic dysfunction. | PMC10214300 |
ICR mice | Cerebral ischemia-reperfusion injury model | Gavage | 5, 10 mg/kg | Once daily for 5 days before ischemia and 14 days after reperfusion | To study the protective effect and mechanism of Rg1 on cerebral ischemia-reperfusion injury, the results showed that Rg1 significantly improved cerebral blood flow, locomotion, and limb coordination, reduced ROS production, increased MAP2 and PSD95 expression, and decreased p-Tau, NOX2, p-PLC, CN, NFAT1, and NLRP1 expression. | PMC9270650 |
C57BL/6 mice | Hypoxia-induced pulmonary hypertension model | Intragastric administration | 5, 10, 20 mg/kg | Once daily for four weeks | Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary hypertension by suppressing the calpain-1/STAT3 signaling pathway, thereby alleviating vascular remodeling, inflammation, and fibrosis. | PMC11258379 |
Sprague-Dawley rats | Myocardial ischemia/reperfusion (MI/R) injury model | Intraperitoneal injection | 10 and 20 mg/kg | Once daily for 7 days | To evaluate the cardioprotective effects of Rg1 against MI/R injury. Results showed that Rg1 dose-dependently reduced myocardial infarct size, inhibited myocardial inflammation and fibrosis, and improved cardiac function. | PMC11583468 |
Sprague-Dawley rats | Abdominal aortic constriction model | Oral | 12 mg/kg | Once daily for 30 days | Ginsenoside Rg1 alleviated AAC-induced cardiac hypertrophy and fibrosis, and improved cardiac function. | PMC8569322 |
Sprague-Dawley rats | Achilles tendinitis model | Oral | 15, 30, 60 mg/kg | Once daily for 30 days | Rg1 promotes the healing of injured tendon in AT rat model through the activation of IGF1R and MAPK signaling pathway | PMC9270649 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.25mL 0.25mL 0.12mL |
6.24mL 1.25mL 0.62mL |
12.48mL 2.50mL 1.25mL |
Tags: Ginsenoside Rg1 | Panaxoside A | Panaxoside Rg1 | Amyloid-β | NF-κB | Apoptosis | β-amyloid peptide | Aβ | Nuclear factor-κB | Nuclear factor-kappaB | Panax ginseng | cognitive function | Aβ levels | NF-κB inhibition | 22427-39-0
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL